Empirico Inc.

États‑Unis d’Amérique

 
Quantité totale PI 69
Rang # Quantité totale PI 19 569
Note d'activité PI 2,8/5.0    90
Rang # Activité PI 7 727
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

28 2
5 1
32 0
1
 
Dernier brevet 2025 - Treatment of fgg related disease...
Premier brevet 2019 - Process to inhibit or eliminate ...
Dernière marque 2024 - EMPIRICO
Première marque 2018 - EMPIRICO

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Treatment of mst1 related diseases and disorders. Disclosed herein are compositions comprising a...
Invention Treatment of fgg related diseases and disorders. Disclosed herein are compositions comprising an ...
Invention Treatment of fgg related hearing disorders. Disclosed herein are compositions comprising an oligo...
P/S Pharmaceutical preparations for preventing or treating diseases of the cardiovascular system, dis...
2023 Invention Treatment of dkk2 related diseases and disorders. Disclosed herein are compositions comprising an...
Invention Treatment of mst1 related diseases and disorders. MST1MST1MST1MST1 to a subject.
Invention Treatment of mtres1 related diseases and disorders. MTRES1MTRES1 gene mutations that include prov...
Invention Small molecule treatment of mtres1 related diseases and disorders. Disclosed herein are compositi...
Invention Gene therapy treatment of mtres1 related diseases and disorders. MTRES1MTRES1 gene mutations that...
Invention Galnac compositions for improving sirna bioavailability. Provided herein, are compositions compr...
Invention Treatment of gpam related diseases and disorders. Metabolic disorders such as liver disorders and...
Invention Treatment of ms4a4e related diseases and disorders. MS4A4EMS4A4EMS4A4E mutations that include pro...
Invention Treatment of sos2 related diseases and disorders. Disclosed herein are compositions comprising an...
Invention Prodrugs of alox-15 inhibitors and methods of using the same. Described herein are compounds and...
Invention Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseases. Pro...
Invention Modified oligonucleotides. Disclosed herein are compositions comprising modified oligonucleotides...
Invention Modified oligonucleotides. Disclosed herein are compositions comprising modified oligonucleotide...
Invention Treatment of hgfac related diseases and disorders. Disclosed herein are compositions comprising a...
Invention Galnac compositions for improving sirna bioavailability. Provided herein, are compositions compri...
2022 Invention Treatment of fgg related diseases and disorders. Disclosed herein are compositions comprising an...
Invention Treatment of thymic stromal lymphopoietin (tslp) related diseases by inhibition of long-form tslp...
Invention Treatment of dkk2 related diseases and disorders. Disclosed herein are compositions comprising a...
Invention Treatment of mst1r related diseases and disorders. Disclosed herein are compositions comprising ...
Invention Treatment of mtres1 related diseases and disorders. Disclosed herein are compositions comprising...
Invention Treatment of plin1 related diseases and disorders. Disclosed herein are compositions comprising ...
Invention Treatment of mst1r related diseases and disorders. MST1RMST1RMST1RMST1R to a subject.
Invention Treatment of plin1 related diseases and disorders. PLIN1PLIN1 gene mutations that include providi...
Invention Treatment of mtres1 related diseases and disorders. Disclosed herein are compositions comprising ...
Invention Treatment of mst1 related diseases and disorders. Disclosed herein are compositions comprising an...
Invention Treatment of angptl4 related diseases. Provided are compositions comprising an oligonucleotide t...
Invention Treatment of angptl4 related diseases. Provided are compositions comprising an oligonucleotide th...
Invention Modulation of coasy expression. Provided herein are specific inhibitors, compositions, methods a...
Invention Modulation of coasy expression. Provided herein are specific inhibitors, compositions, methods an...
Invention Oligonucleotides for treatment of angiopoietin like 4 (angptl4) related diseases. Provided are c...
2021 Invention Treatment of sos2 related diseases and disorders. Disclosed herein are compositions comprising a...
Invention Treatment of sos2 related diseases and disorders. SOS2SOS2SOS2SOS2 to a subject.
Invention Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseases. Pr...
Invention Prodrugs of alox-15 inhibitors and methods of using the same. Described herein are compounds and ...
2019 Invention Process to inhibit or eliminate eosinophilic diseases of the airway and related conditions. Mole...
2018 P/S Pharmaceutical research in connection with human genetics and programmable biology; pharmaceutica...